ClinicalTrials.Veeva

Menu

Incidence of Antibiotic Resistant E.Coli in Patients Undergoing Repeat Prostate Biopsy

University of California Irvine (UCI) logo

University of California Irvine (UCI)

Status

Completed

Conditions

Bacterial Infection

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT00915213
2008-6418

Details and patient eligibility

About

The purpose of this study is to discover how often certain bacteria are found in the rectum at the time of a prostate needle biopsy to diagnose prostate cancer. Certain bacteria are of importance because they can cause serious infection. Antibiotics that urologists commonly use to prevent these bacteria from causing infection are no longer effective. Many physicians around the world are noting increased infections with antibiotic resistant bacteria. Therefore; despite treating patients who are to undergo prostate biopsy with antibiotics, certain patients are being readmitted to the hospital with a serious infection. In order to study the incidence of these particular bacteria, the best method is to culture the bacteria at the time of the biopsy. This involves one rectal culture swab just prior to needle biopsy of the prostate. Once the incidence of these bacteria is known we may take steps to prevent the serious infections that occur as a result of prostate biopsy.

Enrollment

136 patients

Sex

Male

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • adult males
  • repeat prostate biopsy

Exclusion criteria

  • first time prostate biopsy
  • minors

Trial design

136 participants in 1 patient group

Repeat Prostate Biopsy
Description:
Men who undergo repeat prostate biopsy

Trial contacts and locations

3

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems